Nervgen Pharma Corp.
NGENNasdaqCIK 1751912HealthcareFiscal year ends Dec 31
Reports and events: 15 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2520:30 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-25 | 0001104659-26-111004 |
| 2026-09-2412:27 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-24 | 0001104659-26-110225 |
| 2026-08-1311:31 ET | 6-K | Report of a foreign private issuerPeriod 2026-08-13 | 0001104659-26-095467 |
| 2026-07-0221:23 ET | 6-K | Report of a foreign private issuerPeriod 2026-07-02 | 0001104659-26-080432 |
| 2026-06-0121:29 ET | 6-K | Report of a foreign private issuerPeriod 2026-06-01 | 0001104659-26-069028 |
| 2026-05-2620:35 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-26 | 0001104659-26-066307 |
| 2026-05-2221:24 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-22 | 0001104659-26-065821 |
| 2026-05-1820:19 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-18 | 0001104659-26-063212 |
| 2026-05-1520:28 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-15 | 0001104659-26-062618 |
| 2026-04-2721:05 ET | 6-K | Report of a foreign private issuerPeriod 2026-04-27 | 0001104659-26-049508 |
| 2026-03-3111:30 ET | 40-F | Annual report of a Canadian issuerPeriod 2025-12-31 | 0001104659-26-037357 |
| 2026-03-1321:04 ET | 6-K | Report of a foreign private issuerPeriod 2026-03-13 | 0001104659-26-027740 |
| 2026-02-1321:05 ET | 6-K | Report of a foreign private issuerPeriod 2026-02-13 | 0001104659-26-015192 |
| 2026-02-1021:05 ET | 6-K | Report of a foreign private issuerPeriod 2026-02-10 | 0001104659-26-012610 |
| 2026-01-0821:09 ET | 6-K | Report of a foreign private issuerPeriod 2026-01-08 | 0001104659-26-002130 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.